Stem Cell Manufacturing Market Size, Share & Trends Analysis Report By Product | Forecast to 2029
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Are The Future Growth Projections For The Stem Cell Manufacturing Market Size?
In recent times, the size of the stem cell manufacturing market has seen significant growth. It is projected to expand from $17.5 billion in 2024 to $19.17 billion in 2025, marking a compound annual growth rate (CAGR) of 9.5%. The surge witnessed in the historical period can be credited to advancements in biotechnology, research and development efforts, clinical trials and therapeutic applications, the establishment of a regulatory framework, and infrastructure investment.
Anticipations indicate a fast-paced expansion in the stem cell manufacturing market over the upcoming years. The market is predicted to reach a value of $30.03 billion by 2029, with a compound annual growth rate (CAGR) of 11.9%. This growth trajectory during the forecast period could be largely due to the surge in funding & investments, evolving therapeutic applications, the introduction of cell-based therapies, an upswing in clinical trials & approvals, and personalized & patient-specific therapies. Over the forecast period, significant trends will likely encompass a focus on 3d bioprinting, growth in induced pluripotent stem cells (ipscs), the integration of automation & robotics, standardization & scalability, as well as advancements in bioreactor technology.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9402&type=smp
Which Factors Are Steering Growth In The Stem Cell Manufacturing Market?
The increase in the population of older adults, aged 65 and beyond, is predicted to boost the stem cell manufacturing market. This segment of the population, commonly referred to as the geriatric population, experiences a variety of illnesses due to their weakened immune systems and advanced age. With aging, the risk of chronic diseases heightens and the offering of stem cell manufacturing becomes a crucial tool in combating these illnesses. For example, figures from the Population Reference Bureau, a nonprofit organization based in Kenya, indicated in January 2024 that there will be a 47% surge in the population of Americans aged 65 and above, from 58 million in 2022 to 82 million by 2050. This age demographic’s proportion of the total population is forecasted to escalate from 17% to 23% within the same timeframe. Consequently, the escalating geriatric population is fueling the expansion of the stem cell manufacturing market.
How Is The Stem Cell Manufacturing Market Organized By Different Segments?
The stem cell manufacturingmarket covered in this report is segmented –
1) By Product: Consumables; Instruments; Stem Cell Lines
2) By Application: Research Applications; Clinical Application; Cell And Tissue Banking Applications
3) By End User: Pharmaceutical And Biotechnology Companies; Academic Institutes, Research Laboratories And Contract Research Organizations; Hospitals And Surgical Centers; Cell And Tissue Banks; Other End Users
Subsegments:
1) By Consumables: Media And Reagents; Cell Culture Vessels; Assay Kits
2) By Instruments: Bioreactors; Cell Counters; Flow Cytometers
3) By Stem Cell Lines: Embryonic Stem Cell Lines; Adult Stem Cell Lines; Induced Pluripotent Stem Cell Lines (iPSCs)
What Current And Upcoming Trends Are Shaping The Stem Cell Manufacturing Market?
The progressive development of technology is one crucial trend permeating the stem cell manufacturing sector. Multiple entities involved in the market are tapping into these technological improvements for maintaining their competitive stance. For example, in August 2022, an announcement about U.S. Food and Drug Administration (FDA) giving a green light for ZYNTEGLO was made by Bluebird Bio Inc., an American biotech firm. This approval indicates a groundbreaking single-treatment gene therapy now sanctioned for tackling beta-thalassemia in patients requiring frequent red blood cell transfusions. The therapy’s unique feature lies in its ex-vivo approach, where a modified version of the beta-globin gene is embedded into the patient’s hematopoietic stem cells, facilitating them to produce standard quantities of hemoglobin. This pioneering treatment targets achieving transfusion autonomy, considerably reducing the treatment difficulties experienced by beta-thalassemia patients. The authorization from the FDA for ZYNTEGLO ignites significant advancement in the gene therapy field, potentially offering a remedy and ameliorating the life quality for the impacted individuals.
Who Are The Most Influential Companies In The Stem Cell Manufacturing Market?
Major companies operating in the stem cell manufacturing market include Thermo Fisher Scientific Inc., Merck Millipore, Stemcell Technologies, Fujifilm Holdings Corporation, Takara Bio Group, Lonza Group AG, Sartorius AG, Bio-Rad Laboratories, Becton Dickinson and Company, Bio-Techne Corporation, Miltenyi Biotec, Terumo BCT Inc., Corning Inc., Eppendorf AG, ViaCyte Inc., Merck KGaA, Danaher Corporation, Vericel Corporation, American Cryostem Corporation, Cellgenix GMBH, Aspen Neuroscience Inc., Magenta Therapeutics Inc, Pluristem Therapeutics Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., 3D Biomatrix Inc., Worthington Biochemical Corporation, Bico Group
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/stem-cell-manufacturing-global-market-report
Which Region Dominates The Stem Cell Manufacturing Market Today?
North America was the largest region in the stem cell manufacturing market in 2024. Europe was the second-largest region in the stem cell manufacturing market. The regions covered in the stem cell manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=9402&type=smp
Browse Through More Reports Similar to the Global Stem Cell Manufacturing Market 2025, By The Business Research Company
Neurology Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report
Neurodegenerative Disorder Therapeutic Global Market Report 2025
Neurophysiology Devices And Equipment Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
